Kaiji Hu

Shanghai University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

24h-index2.0kcitations65works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Research and Splicing(14), Entomopathogenic Microorganisms in Pest Control(10), Sarcoma Diagnosis and Treatment(9), Cytokine Signaling Pathways and Interactions(8), Glioma Diagnosis and Treatment(6)

Publications64 total

Cu<sup>0</sup>-Promoted Truce–Smiles Rearrangement for Aryl-Difluoromethylenation of C═C Bonds via a Reductive Radical–Polar Crossover Process
The Journal of Organic Chemistry·2024· 2 cited
Supplementary Figure 2 from Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
2023Open Access
Supplementary Table 1 from Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
2023Open Access
Supplementary Table 1 from Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
2023Open Access
Supplementary Figure 1 from Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
2023Open Access
Data from Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
2023Open Access
Supplementary Figure 2 from Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
2023Open Access
Supplementary Figure 1 from Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
2023Open Access
Data from Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
2023Open Access
Supplementary Methods and Materials, Figures 1-6 from Y-Box Binding Protein-1 Induces the Expression of &lt;i&gt;CD44&lt;/i&gt; and &lt;i&gt;CD49f&lt;/i&gt; Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance
2023Open Access
Data from Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
2023Open Access
Supplementary Figure 2 from Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice
2023Open Access
Supplementary Figure 1 from Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
2023Open Access
Supplementary Figure 1 from Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice
2023Open Access
Data from Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice
2023Open Access
Data from Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice
2023Open Access
Supplementary Methods and Materials, Figures 1-6 from Y-Box Binding Protein-1 Induces the Expression of &lt;i&gt;CD44&lt;/i&gt; and &lt;i&gt;CD49f&lt;/i&gt; Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance
2023Open Access
Data from Y-Box Binding Protein-1 Induces the Expression of &lt;i&gt;CD44&lt;/i&gt; and &lt;i&gt;CD49f&lt;/i&gt; Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance
2023Open Access
Data from Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
2023Open Access
Supplementary Figure 1 from Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Sandra E. Dunn(34), Abbas Fotovati(17), Anna L. Stratford(16), Arezoo Astanehe(13), Alastair Davies(12), Connie J. Eaves(12), Cathy Lee(11), Eugene Park(9), Kristen M. Reipas(9), Jennifer Law(8), Mary Rose Pambid(8), John Webster(8), Jianxiong Li(7), Rachel Berns(6), Mien‐Chie Hung(6), Peter Eirew(6), Karen To(5), Isabelle M. Berquin(5), Michelle Y.C. Wang(5), Samah Abu‐Ali(5)